NU.V - NeutriSci International Inc.

TSXV - TSXV Delayed Price. Currency in CAD
0.085
0.000 (0.00%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close0.085
Open0.080
Bid0.075 x 0
Ask0.085 x 0
Day's Range0.075 - 0.085
52 Week Range0.060 - 0.350
Volume307,025
Avg. Volume250,879
Market Cap8.504M
Beta4.12
PE Ratio (TTM)N/A
EPS (TTM)-0.023
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswirelast month

    Nutritional High and NeutriSci International to Launch Cannabis-Infused Tablets July 11th

    NeutriSci International Inc. ("NeutriSci") (NU.V) (NRXCF) (1N9.F) the innovator and pioneer behind neuenergy® is pleased to provide an update on its previously announced partnership with Nutritional High International Inc. (the “Company” or “Nutritional High”) (CSE:EAT) (SPLIF) (2NU.F) (see press release dated May 30th, 2018). As of July 11th, 2018, NeutriSci and Nutritional High will commence the production process of its newly developed chewable, sublingual THC product (“Tablets”) for sale and distribution in the state of California. The Tablets will be produced at the Company’s Pasa Verde manufacturing facility, located in Sacramento, California.

  • GlobeNewswirelast month

    Nutritional High and NeutriSci to Launch Cannabis-Infused Nu Energy Tablets July 11th

    Nutritional High International Inc. (the “Company” or “Nutritional High”) (CSE:EAT) (SPLIF) (2NU.F) is pleased to provide an update on its previously announced partnership with NeutriSci International Inc. ("NeutriSci") (NU.V) (NRXCF) (1N9.F) (see press release dated May 30th, 2018). As of July 11th, 2018, NeutriSci and Nutritional High will commence the production process of its newly developed chewable, sublingual THC product (“Nu Energy Tablets”) for sale and distribution in the state of California. The Nu Energy Tablets will be produced at the Company’s Pasa Verde manufacturing facility, located in Sacramento, California.

  • GlobeNewswire2 months ago

    NeutriSci Provides Update on Patent Pending Technology

    Preliminary research data indicate that cannabinoid and stilbenoid formulations prepared using the Cryolisation process increase absorption rates of cannabinoid compounds 4 – 5 times over consumption of cannabinoid compounds alone.

  • GlobeNewswire3 months ago

    NeutriSci and Nutritional High Enter Into Agreement to Develop, Manufacture & Distribute Cannabis Infused Products

    Subject to the negotiation of a definitive agreement, NeutriSci and Nutritional High will develop products which will be manufactured and distributed by Nutritional High in US states which permit the sale of cannabis infused products.  The tablets will combine the benefits of NeutriSci and Nutritional High’s existing technologies and ingredient mixes.  The tablets will be quick dissolving and will offer a measured dose of pure THC or CBD oil, combined with the powerful bio-availability & antioxidant properties of pterostilbene.

  • Newsfile5 months ago

    Neutrisci Files Patent Application

    Vancouver, British Columbia--(Newsfile Corp. - March 1, 2018) - NeutriSci International Inc. (TSXV: NU) (OTCQB: NRXCF) (FSE: 1N9) (the "Company" or "NeutriSci")  the innovator and pioneer behind neuenergy®, is pleased to announce the filing of a new U.S. provisional patent application (United States Provisional Patent No. 62/628,735; Compositions Comprising Co-crystals of Stilbenoids and Cannabinoids) relating to compositions comprising pterostilbene and other stilbenoids in formulations which improve the dissolution rate and bioavailability of cannabinoid compounds.Cannabinoids ...

  • Newsfile6 months ago

    Neutrisci and Lexaria Bioscience Enter Global Licensing Agreement

    Vancouver, British Columbia--(Newsfile Corp. - February 26, 2018) - NeutriSci International Inc. (TSXV: NU) (OTCQB: NRXCF) (FSE: 1N9) (the "Company" or "NeutriSci") and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) ("Lexaria") are pleased to announce that they have revised their joint venture agreement such that NeutriSci now owns 100% of Ambarii Trade Corporation ("Ambarii"), and Lexaria has granted to NeutriSci, an Intellectual Property License and Supply Agreement (the "License Agreement") for the manufacturing and sale of CBD ...

  • ACCESSWIRE6 months ago

    Lexaria and Neutrisci Enter Global Licensing Agreement

    KELOWNA, BRITISH COLUMBIA / ACCESSWIRE / February 26, 2018 / Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the "Company" or "Lexaria") a drug delivery platform innovator, announces ...

  • Marketwired7 months ago

    NeutriSci Announces Major Sponsorship With Tennis Star Genie Bouchard

    NeutriSci International Inc. , the innovator and pioneer behind neuenergy®, is pleased to announce a one-year sponsorship deal with Canadian and International tennis...

  • Newsfile7 months ago

    Neutrisci Announces a Major R&D MOU with Scientus Pharma to Develop a Medical Cannabinoid Retail Product

    Vancouver, British Columbia--(Newsfile Corp. - January 8, 2018) - NeutriSci International Inc. (TSXV: NU) (OTCQB: NRXCF) (FSE: 1N9) (the "Company" or "NeutriSci"), the innovator and pioneer behind neuenergy®, is pleased to announce it has entered into a major R&D Memorandum of Understanding with Scientus Pharma Inc. ("Scientus Pharma"). Under the terms of the MOU, both companies have agreed to share their technologies to develop, test, produce, and distribute a medical cannabinoid product for existing ...

  • Marketwired9 months ago

    NeutriSci Announces Pending Approval From Japanese Government for Distribution of CBD Products Through Naturally Splendid

    NeutriSci International Inc. , the innovator and pioneer behind neuenergy®, is pleased to announce that its partner in Japan and South Korea for Ambarii Corporation...